An Observational Study of Patients With Autoimmune Disease

Sponsor
Target PharmaSolutions, Inc.
Study ID
NCT05842824
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Autoimmune Diseases

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

TARGET-AUTOIMMUNE is an observational research study to conduct a comprehensive review of outcomes for patients with autoimmune and related diseases. .

Key Dates

First listed
May 6, 2023
Start date
Mar 31, 2025
Status verified
Apr 2024
Primary completion
Dec 31, 2038
Completion
Dec 31, 2038

Study Design

Enrollment
500,000 participants (estimated)

Arms

  • Arm: Disease Cohort
    Observational
  • Arm: Engaged Cohort
    Observational

Primary Outcome Measure

To characterize the natural history of disease in patients with autoimmune disease of various etiologies. [ Time Frame: 15 Years ]

Related Studies